Cooper EBITDA 2010-2024 | COO
Cooper annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Cooper EBITDA for the quarter ending October 31, 2024 was $0.289B, a 26.71% increase year-over-year.
- Cooper EBITDA for the twelve months ending October 31, 2024 was $1.081B, a 19.98% increase year-over-year.
- Cooper 2024 annual EBITDA was $1.081B, a 19.98% increase from 2023.
- Cooper 2023 annual EBITDA was $0.901B, a 5.52% increase from 2022.
- Cooper 2022 annual EBITDA was $0.854B, a 4.74% increase from 2021.
Cooper Annual EBITDA
(Millions of US $) |
| 2024 |
$1,081 |
| 2023 |
$901 |
| 2022 |
$854 |
| 2021 |
$815 |
| 2020 |
$599 |
| 2019 |
$828 |
| 2018 |
$678 |
| 2017 |
$618 |
| 2016 |
$522 |
| 2015 |
$428 |
| 2014 |
$445 |
| 2013 |
$431 |
| 2012 |
$395 |
| 2011 |
$326 |
| 2010 |
$284 |
| 2009 |
$242 |
Cooper Quarterly EBITDA
(Millions of US $) |
| 2024-10-31 |
$289 |
| 2024-07-31 |
$282 |
| 2024-04-30 |
$260 |
| 2024-01-31 |
$250 |
| 2023-10-31 |
$228 |
| 2023-07-31 |
$246 |
| 2023-04-30 |
$187 |
| 2023-01-31 |
$239 |
| 2022-10-31 |
$193 |
| 2022-07-31 |
$222 |
| 2022-04-30 |
$226 |
| 2022-01-31 |
$213 |
| 2021-10-31 |
$206 |
| 2021-07-31 |
$180 |
| 2021-04-30 |
$221 |
| 2021-01-31 |
$209 |
| 2020-10-31 |
$177 |
| 2020-07-31 |
$143 |
| 2020-04-30 |
$97 |
| 2020-01-31 |
$182 |
| 2019-10-31 |
$217 |
| 2019-07-31 |
$213 |
| 2019-04-30 |
$218 |
| 2019-01-31 |
$180 |
| 2018-10-31 |
$193 |
| 2018-07-31 |
$185 |
| 2018-04-30 |
$144 |
| 2018-01-31 |
$157 |
| 2017-10-31 |
$156 |
| 2017-07-31 |
$160 |
| 2017-04-30 |
$163 |
| 2017-01-31 |
$139 |
| 2016-10-31 |
$122 |
| 2016-07-31 |
$152 |
| 2016-04-30 |
$138 |
| 2016-01-31 |
$111 |
| 2015-10-31 |
$92 |
| 2015-07-31 |
$104 |
| 2015-04-30 |
$116 |
| 2015-01-31 |
$116 |
| 2014-10-31 |
$82 |
| 2014-07-31 |
$129 |
| 2014-04-30 |
$121 |
| 2014-01-31 |
$113 |
| 2013-10-31 |
$94 |
| 2013-07-31 |
$125 |
| 2013-04-30 |
$112 |
| 2013-01-31 |
$100 |
| 2012-10-31 |
$110 |
| 2012-07-31 |
$105 |
| 2012-04-30 |
$92 |
| 2012-01-31 |
$88 |
| 2011-10-31 |
$93 |
| 2011-07-31 |
$77 |
| 2011-04-30 |
$84 |
| 2011-01-31 |
$72 |
| 2010-10-31 |
$86 |
| 2010-07-31 |
$75 |
| 2010-04-30 |
$63 |
| 2010-01-31 |
$60 |
| 2009-10-31 |
$67 |
| 2009-07-31 |
$56 |
| 2009-04-30 |
$62 |
| 2009-01-31 |
$58 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$19.559B |
$3.895B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
